Podcasts about hiv screening

Peter Selwyn, one of today's guests, has been caring for people living with HIV for over 40 years.  In that time, care of people with HIV has changed dramatically.  Initially, there was no treatment, then treatments with marginal efficacy, complex schedules, and a tremendous burden of side effects and drug-drug interactions.  The average age at death was in the 30s. Now, more people in the US die with HIV rather than from HIV.  Treatment regimens are simplified, and the anti-viral drugs are well tolerated.  People are living with HIV into advanced ages.  The average age at death is likely in the 60s.  Nearly half of people living with HIV are over age 55.  One in 10 people with newly diagnosed HIV is an older adult.  Our second guest, Meredith Greene, is a geriatrician and researcher who focuses on care of older adults living with HIV, in the US and Africa. On today's podcast we discuss: Implications of aging with HIV for clinical care Loneliness and social isolation among older adults living with HIV Persistence of stigma Need to consider HIV in the differential diagnosis for older adults Screening for HIV Screening for osteoporosis in people living with HIV Dementia and cognitive impairment risk in people living with HIV When to stop anti-virals near the end of life Toward the end we speak to the moment.  More older adults live with HIV in SubSaharan Africa and the global South than anywhere else in the world.  Funding for research and clinical care is at risk, as USAID and PEPFAR (which is under USAID), are shuttered.  Millions of lives are at stake.  Meredith wore a shirt that said Silence=death. Eric gave me the hook during my live cover of One, by U2, a song released in 1992 whose proceeds went entirely to AIDS research.  I couldn't help it, forgive me dear listeners, I had to do a longer than usual cut at the start! -Alex Smith   Useful links: Peter's article on the evolution of HIV: https://link.springer.com/article/10.1007/s11524-011-9552-y Peter's book Surviving the Fall: Personal Journey of an AIDS Doctor PEPFAR:  Global Health Policy | KFF   Articles: Geriatric Syndromes in Older HIV-Infected Adults - PMC Loneliness in Older Adults Living with HIV Management of Human Immunodeficiency Virus Infection in Advanced Age https://pmc.ncbi.nlm.nih.gov/articles/PMC3684249/ About Act-up for those who might know the Silence=Death t-shirt reference: https://www.npr.org/2021/06/16/1007361916/act-up-a-history-of-aids-hiv-activism https://www.newyorker.com/magazine/2021/06/14/how-act-up-changed-america

https://302.buzz/PM-WhatAreYourThoughtsWhen you think of HIV, do you breathe a sigh of relief thinking “well, at least we don't have to deal with THAT anymore”? Has it completely fallen off your radar as a medical issue that is “under control”? Well, then it's important that you listen to this episode. Dr. Gaggino talks with Dr. Julia Rosebush and Britt Hodgdon, LCSW. Together they dive into the topic of HIV and trauma recovery. They'll share insights on how to support individuals living with HIV and overcome stigma, as well as discussing the concept of undetectable equals untransmittable and how it impacts communication and relationships. You'll also hear about the role of trauma recovery and somatic therapy in destigmatizing HIV and promoting self-perception. This is a powerful conversation on how to thrive with HIV and befriend it. [00:33 -18:52] Addressing HIV StigmaHIV stigma still exists despite advances in treatment and prevention.Stigmatizing attitudes can negatively affect the mental health and well-being of those living with HIV. HIV stigma can lead to discrimination in healthcare and other areas of life.Advocacy and education can help decrease HIV stigma and empower those living with the virus.Language also plays a role in HIV stigma, and using non-stigmatizing terminology is important in reducing stigma.[18:53- 33:22] HIV and Undetectable Viral Load Undetectable viral load means untransmittable HIV to sexual partnersYears of research have solidified the undetectable equals untransmittable concept.Youth should not be afraid of transmitting HIV if they achieve an undetectable viral load. Normalizing conversations about HIV and reducing stigma surrounding the virusEncouraging youth to prioritize their sexual health and seek appropriate medical care if needed.[33:23 -46:07] Communicating about HIV Status: Language and Approaches for Young PeopleImportance of confidentiality and privacy when discussing HIV statusStrategies for building trust and rapport with young people when discussing HIV. Highlighting the effectiveness of antiretroviral therapy for managing HIVEncouraging young people to take ownership of their health and prioritize self-care.The role of healthcare professionals in educating and supporting young people living with HIV[46:08 - 54:38] Improving Conversations about Sexuality, Identity, and Gender with Young People Professionals need to be fluent in “young-person-speak” to have effective conversations about sexuality, identity, and gender.Assumed binaries should be avoided, and young people should be asked to name who they are and how they want to be referred to.Centering young people in conversations about their bodies can be a relief for the medical field and benefit young people.There is room for growth among professionals in this space.Rethinking the way we talk to young people about sexuality, identity, and gender is ultimately necessary for caring for young people and families. [54:39 - 1:00:03] Closing segment TakeawayYou can reach Dr. Julia RosebushLinkedIn: Julia Rosebush, DO, FAAP | LinkedIn Hashtags: #hivprevention #hivawareness #gettingtozero...

In this episode, Babafemi Taiwo, MBBS, discusses strategies for reaching people with HIV who are not yet diagnosed. His overview includes:HIV diagnosis by global regionDisparities in serostatus awarenessPatient perspective on importance of HIV testingBarriers to HIV diagnosisComplications from late HIV diagnosisStrategies to improve rates of HIV testingPresenter:Babafemi Taiwo, MBBS​Gene Stollerman Professor of Medicine​Chief, Division of Infectious Diseases​Northwestern UniversityFeinberg School of Medicine​Chicago, IllinoisPanelists:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhDDirectorDesmond Tutu HIV Centre​Past PresidentInternational AIDS Society​Faculty of Health SciencesUniversity of Cape TownCape Town, South Africa​Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD​Chief and DirectorVHS Infectious Diseases Medical Centre​Director, Chennai Antiviral Research and Treatment (CART) Clinical Research Site​Voluntary Health Services​Chennai, IndiaChloe Orkin, MBChB, FRCP, MDProfessor of HIVQueen Mary, University of London​Consultant Physician​Lead for HIV ResearchBarts Health NHS Trust​The Royal London Hospital​London, United Kingdom​Content based on an online CME program supported by an independent educational grant from Gilead Sciences.Follow along with the slides: https://bit.ly/3PJRthDLink to full program:https://bit.ly/3AE2AV1

Dr. Lee Connor is an infectious disease specialist at Hamilton Physician Group-Specialty Care located in Dalton, Georgia. For more information or an appointment at Hamilton Physician Group-Specialty Care, call 706-529-3072 or visit HamiltonHealth.com/specialtycare.  This program in no way seeks to diagnose or treat illness or to replace professional medical care. Please see your healthcare provider if you have a health problem.

In this episode from the series “Key Decisions in HIV Care,” Latesha Elopre, MD, MSPH, and Karine Lacombe, MD, PhD, discuss important considerations for PrEP in cisgender men and transgender women, including:Discussion of the PrEP gap and racial and gender disparities in PrEP access CDC, EACS, and WHO guidance on PrEP eligibility PrEP regimens currently recommended for adults and adolescents including FTC/TDF daily, FTC/TAF daily, and long-acting cabotegravir Data from clinical trials on the efficacy of FTC/TDF daily for men including Partners PrEP, TDF2, iPrEx, iPrEx OLE, and PROUD Data from the ANRS IPERGAY study on the use of FTC/TDF on demand Data from the DISCOVER trial on the use of FTC/TAF for PrEP Data from the HPTN 083 study on the use of long-acting cabotegravir as PrEP for cisgender men Clinical monitoring and considerations during PrEP usePresenters:Latesha Elopre, MDAssociate ProfessorDivision of Infectious DiseasesAssistant Dean of Diversity and InclusionGeneral Medical EducationUniversity of Alabama at BirminghamBirmingham, AlabamaKarine Lacombe, MD, PhDProfessorUMR-S1136Sorbonne UniversityHead, Infectious Diseases DepartmentSt Antoine Hospital, AP-HPParis, FranceContent based on an online CME program supported by educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; and ViiV Healthcare.Follow along with the slides at:https://bit.ly/3uqPje3Link to full program:https://bit.ly/3q2DlGd

In this episode from the series “Key Decisions in HIV Care,” Latesha Elopre, MD, MSPH, and Karine Lacombe, MD, PhD, discuss important considerations for PrEP in cisgender women, including: Discussion of the PrEP gap and racial and gender disparities in PrEP accessCDC, EACS, and WHO guidance on PrEP eligibilityPrEP regimens currently recommended for adults and adolescents including FTC/TDF daily, FTC/TAF daily, and long-acting cabotegravirData from phase III trials on the efficacy of FTC/TDF daily for women including Partners PrEP, TDF, VOICE, and FEM-PrEPPharmacokinetic data of FTC/TDF and FTC/TAF in the female genital tract and discussion of why on-demand dosing of FTC/TDF is not recommended in cisgender womenData and recommendations for the use of the dapivirine ring from ASPIRE and The Ring Study and their open-label extensions, DREAM and HOPEData from the HPTN084 study on the use of long-acting cabotegravir as PrEP for cisgender womenRecommendations for the use of PrEP during pregnancy and breastfeedingClinical monitoring and considerations during PrEP usePresenters:Latesha Elopre, MD, MSPHAssociate ProfessorDivision of Infectious DiseasesAssistant Dean of Diversity and InclusionGeneral Medical EducationUniversity of Alabama at BirminghamBirmingham, Alabama Karine Lacombe, MD, PhDProfessorUMR-S1136Sorbonne UniversityHead, Infectious Diseases DepartmentSt Antoine Hospital, AP-HPParis, France Content based on an online CME program supported by educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; and ViiV Healthcare.Follow along with the slides at: https://bit.ly/36s2ovBLink to full program:https://bit.ly/3q2DlGd

In this episode, Jason Schafer, PharmD, MPH, explores key considerations for the use of long-acting injectable pre-exposure prophylaxis (PrEP).- Listen as he gives his perspectives on:- The FDA approval of long-acting cabotegravir for PrEP- Healthcare professionals' clinical concerns with long-acting injectable antiretroviral therapy- Considerations for long-acting cabotegravir as PrEPDosing and administrationManaging missed dosesDiscontinuationDelays in HIV diagnoses found in the HPTN 083 study in men- CDC recommendations for HIV screening while receiving PrEPPresenter:Jason Schafer, PharmD, MPHProfessor and Vice ChairJefferson College of PharmacyThomas Jefferson UniversityPhiladelphia, Pennsylvania  Follow along with the slides at: https://bit.ly/3wugMOCSee the entire program at: https://bit.ly/3q2DlGd

We’re in the midst of a global pandemic and, of course, everyone’s attention is focused on COVID-19. Other podcasts have excellent coverage of this situation. In this episode, we’ll be discussing other important infections that continue to affect our communities: HIV, hepatitis C, and syphilis. Over the past year, the UC Davis ED implemented a massive screening effort to identify patients who have become infected. Dr. Larissa May explains how the screening works and some of the surprising trends we’ve seen. Infection rates were higher than expected and many patients had no idea they were infected! One patient tells us how screening positive for HIV, and being connected to care, changed his life.  This topic, as with so many issues we cover, brings up the broader question: what is the role of the emergency department in the healthcare system? We will explore this further in an upcoming episode and we would love to hear from YOU.  What do YOU see as the role of the emergency department in the broader health system? Send us your answer via on social media, @empulsepodcast, or through our website, ucdavisem.com. And please pass the word along to your friends and colleagues! ***Please rate us and leave us a review on iTunes! It helps us reach more people.*** Hosts: Dr. Julia Magaña, Assistant Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Assistant Professor of Emergency Medicine at UC Davis Guest: Dr. Larissa May, Professor of Emergency Medicine with a Masters in Emerging Infectious Diseases, and Director of Emergency Department Antibiotic Stewardship at UC Davis. Resources: ACEP Policy Statement on HIV testing and screening in the ED Centers for Disease Control and Prevention (CDC) resources: Ending the HIV Epidemic: A Plan for America. HIV Nexus Clinician Resources Haukoos JS, Lyons MS, Rothman RE. The Evolving Landscape of HIV Screening in the Emergency Department. Ann Emerg Med. 2018 Jul;72(1):54-56. doi: 10.1016/j.annemergmed.2018.01.041. Epub 2018 Feb 17. PubMed PMID: 29459057; Leblanc J, Hejblum G, Costagliola D, Durand-Zaleski I, Lert F, de Truchis P, Verbeke G, Rousseau A, Piquet H, Simon F, Pateron D, Simon T, Crémieux AC; DICI-VIH (Dépistage Infirmier CIblé du VIH) Group. Targeted HIV Screening in Eight Emergency Departments: The DICI-VIH Cluster-Randomized Two-Period Crossover Trial. Ann Emerg Med. 2018 Jul;72(1):41-53.e9. doi: 10.1016/j.annemergmed.2017.09.011. Epub 2017 Oct 31. *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Audio Productions for audio production services.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care stories included Purdue Pharma filing for bankruptcy; new data showing the number of people who get screened for HIV at least once falls far short of what CDC recommends; findings that most US hospital markets are now highly concentrated. Read more about the stories in this podcast: What We're Reading: Purdue Pharma Files for Bankruptcy; Rise in Uninsured Immigrants; Spiked CBD in Maryland: https://www.ajmc.com/newsroom/what-were-reading-purdue-pharma-files-for-bankruptcy-rise-in-uninsured-immigrants-spiked-cbd-in-maryland How Many People Actually Get Screened for HIV? https://www.ajmc.com/newsroom/how-many-people-actually-get-screened-for-hiv Nearly 75% of US Hospital Markets Highly Concentrated, HCCI Report Shows: https://www.ajmc.com/newsroom/nearly-75-of-us-hospital-markets-highly-concentrated-hcci-report-shows What We're Reading: Fast Track Designation for Dapagliflozin; California Advocates Against Vaping; Measles Cases Fading: https://www.ajmc.com/newsroom/what-were-reading-fast-track-designation-for-dapagliflozin-california-advocate-against-vaping-measles-cases-fading- Amgen Posts Updates on Triplet Therapy Using Carfilzomib: https://www.ajmc.com/newsroom/amgen-posts-updates-on-triplet-therapy-using-carfilzomib Managed Care for Long-Stay Nursing Home Residents: An Evaluation of Institutional Special Needs Plans: https://www.ajmc.com/journals/issue/2019/2019-vol25-n9/managed-care-for-long-stay-nursing-home-residents-an-evaluation-of-institutional-special-needs-plans

On this episode, host Jason Woods speaks with Dr. Amy Grover about HIV screening in the pediatric emergency department. Dr. Grover works in both the section of emergency medicine and hospital medicine and has an interest in HIV screening. The highlights: An estimated 50% of adolescents with HIV do not know they have contracted HIV… The post Episode 21: HIV Screening in the Pediatric ED appeared first on Little Big Med.

Rochelle P. Walensky, MD, MPH joins JAMA Network editors to discuss the importance of the US Preventive Services Task Force recommendation statements on HIV screening and preexposure prophylaxis (PrEP). Read the article here: https://ja.ma/2NsZ9K4. JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.

Interview with Paul A. Volberding, MD, and Hyman Scott, MD MPH, authors of HIV Screening and Preexposure Prophylaxis Guidelines: Following the Evidence

In this Medical News podcast, Rita Rubin interviews the founders of One Tent Health, a nonprofit free HIV screening initiative that serves high-risk neighborhoods in Washington, DC.

HEALTHY MONDAYS with AAPINA of NV- Oct. 15, 2018 - HIV Screening and Prevention Hosted by Dr. Marife Aczon-Armstrong of AAPINA of NVGuest: Raymond "Austin" Nation, PhD, RN, PHN ----Healthy Mondays is an independent production of AAPINA of Nevada. Contents of this podcast/radio program are solely produced and presented by The Asian American/Pacific Islander Nurses Association of Nevada. Contact AAPINA of Nevada through their website: http://aapina.org/about-us/aapina-of-nevada/

HEALTHY MONDAYS with AAPINA of NV- Oct. 15, 2018 - HIV Screening and Prevention Hosted by Dr. Marife Aczon-Armstrong of AAPINA of NVGuest: Raymond "Austin" Nation, PhD, RN, PHN ----Healthy Mondays is an independent production of AAPINA of Nevada. Contents of this podcast/radio program are solely produced and presented by The Asian American/Pacific Islander Nurses Association of Nevada. Contact AAPINA of Nevada through their website: http://aapina.org/about-us/aapina-of-nevada/

In the eighth episode of our "Coding with Ann" podcast series for reproductive health care providers, Ann Finn will review codes that can be used for billing STD and HIV screenings. This podcast series assists family planning providers with appropriate and timely reimbursement. To download a copy of the transcript, please visit http://www.ctcfp.org/coding-with-ann/.

This seminar will explore issues around HIV screening in TB clinics, including barriers to provider-initiated HIV testing, successful strategies to improve screening rates, and interventions for strengthening TB-HIV collaborations. The format will include an overview of the CDC's recommendations, perspectives and experiences of TB programs, and a case study. Originally recorded August 28, 2012.

This seminar will explore issues around HIV screening in TB clinics, including barriers to provider-initiated HIV testing, successful strategies to improve screening rates, and interventions for strengthening TB-HIV collaborations. The format will include an overview of the CDC's recommendations, perspectives and experiences of TB programs, and a case study. Originally recorded August 28, 2012.

This webinar explores issues around HIV screening in TB clinics, including barriers to provider-initiated HIV testing, successful strategies to improve screening rates, and interventions for strengthening TB-HIV collaborations. The format will include an overview of the CDC's recommendations, perspectives and experiences of TB programs, and a case study. Originally recorded August 28, 2012.

Dr. Ronald Bayer is a Professor of Sociomedical Sciences at the Mailman School of Public Health at Columbia University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. R. Bayer and G. M. Oppenheimer. Routine HIV Testing, Public Health, and the USPSTF - An End to the Debate. N Engl J Med 2013;368:881-4.

The U.S. Preventive Services Task Force has issued a new draft recommendation that urges everyone in the country -- adolescents and adults between 15 and 65 -- to get an HIV test. (November 20, 2012)